Ankle Nitin R, Yeramalla Vijay, Havaldar Rajesh Radhakrishna
Department of ENT and Head and Neck Surgery, KAHER's J. N. Medical College, Belagavi, Karnataka India.
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):5296-5300. doi: 10.1007/s12070-020-02252-7. Epub 2020 Nov 5.
Tonsillectomy is one of the common surgeries performed by Otorhinolaryngologists and is associated with several morbidities with pain being the commonest, which can cause considerable delay in oral intake and discharge from the hospital. As a commonly performed day care procedure nowadays, pain control is much better than what it used to be previously observed. Therefore newer drugs are being constantly studied inorder to give better analgesia and post operative comfort to the patient with minimal side effects. The main obstacle being finding the best medical method to control pain with minimum side effects, but at the same time making sure that the patient is adequately hydrated and they resume regular eating as soon as possible. Our aim is to study the role of pre-incisional 0.5% bupivacaine versus normal saline infiltration in post-tonsillectomy analgesia. Over a period of 1 year, 30 patients with each group of 15 were compared for the efficacy of 0.5% bupivacaine and 0.9% normal saline in post-operative tonsillectomy pain management. After thorough clinical examination and investigations, all patients underwent tonsillectomy by dissection and snare method. After intubation, 0.5% bupivacaine or normal saline was infiltrated in the tonsillar fossa and pain scores was obtained using Visual Analogue Scale (V.A.S) at 6, 12 and 24 h post operatively. Using Mann-Whitney non-parametric statistical test, inter-group analysis was done which showed highly significant -value (<0.0001) indicating that the pre-incisional bupivacaine infiltration is highly effective in reducing the post-tonsillectomy pain. Hence, we recommend the routine use of pre-incisional peritonsillar infiltration of 0.5% bupivacaine in all tonsillectomy/adenotonsillectomy cases, irrespective of the age of the patient to reduce the post tonsillectomy pain and other discomfort associated with it.
扁桃体切除术是耳鼻喉科医生进行的常见手术之一,它会引发多种并发症,其中疼痛最为常见,这可能导致患者经口进食和出院时间大幅延迟。作为如今常见的日间手术,疼痛控制比以前有了很大改善。因此,人们不断研究新型药物,以便在副作用最小的情况下为患者提供更好的镇痛效果和术后舒适度。主要障碍在于找到控制疼痛且副作用最小的最佳医疗方法,同时要确保患者有充足的水分摄入,并尽快恢复正常饮食。我们的目的是研究术前切口处注射0.5%布比卡因与生理盐水浸润在扁桃体切除术后镇痛中的作用。在1年的时间里,对两组各15例患者进行比较,观察0.5%布比卡因和0.9%生理盐水在扁桃体切除术后疼痛管理中的效果。经过全面的临床检查和各项检查后,所有患者均采用剥离圈套法进行扁桃体切除术。插管后,在扁桃体窝注射0.5%布比卡因或生理盐水,并在术后6、12和24小时使用视觉模拟评分法(V.A.S)获取疼痛评分。使用曼-惠特尼非参数统计检验进行组间分析,结果显示具有高度显著性的P值(<0.0001),表明术前切口处注射布比卡因浸润在减轻扁桃体切除术后疼痛方面非常有效。因此,我们建议在所有扁桃体切除术/腺样体扁桃体切除术病例中常规使用术前切口处扁桃体周围浸润0.5%布比卡因,无论患者年龄大小,以减轻扁桃体切除术后疼痛及与之相关的其他不适。